Coronary Hemodynamics in Heart Failure and Effects of Therapeutic Interventions

Journal of Cardiac Failure

Volumn 15, Issue 2, 2009, Pages 116-123

  Chatterjee, Kanu ^a  

^a UCSF Medical Center at Parnassus   (United States)

Author keywords

Coronary hemodynamics; effects of therapy; systolic heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; CARVEDILOL; CILAZAPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; ENALAPRIL; ENALAPRILAT; GLYCERYL TRINITRATE; HYDRALAZINE; LEVOSIMENDAN; LOSARTAN; METOPROLOL; NEBIVOLOL; NITRATE; NORADRENALIN; PERINDOPRIL; PHOSPHODIESTERASE INHIBITOR;

ADRENERGIC ACTIVITY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; DRUG EFFECT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIDE EFFECT; SYSTOLIC HEART FAILURE;

APOPTOSIS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DISEASE PROGRESSION; HEART FAILURE, SYSTOLIC; HEMODYNAMICS; HUMANS; MYOCARDIAL ISCHEMIA; NEUROTRANSMITTER AGENTS; OXYGEN CONSUMPTION; TREATMENT OUTCOME;

EID: 60849118095     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.01.001     Document Type: Review

References (68)

1. Feliciano L., and Henning R.J. Coronary blood flow: physiologic and pathophysiologic regulation. Clin Cardiol 2 (1999) 775-786
2. De Marco T., Chatterjee K., Rouleau J.L., and Parmley W.W. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J 115 (1988) 809-815
3. Kass D.A. Myocardial mechanics. Heart failure. In: Pool-Wilson P.A., Colucci W.S., Massie B.M., Chatterjee K., and Coats A.J.S. (Eds) (1997), Churchill Livingstone, New York p. 7, 871-108
4. Chatterjee K. Dilated cardiomyopathy and coronary arteries. Pan vascular medicine. In: Lanzer P., and Topol E.J. (Eds) (2002), Springer, New York p. 62, 9871-94
5. Frick M.H., Valle M., Korhola O., et al. Analysis of coronary collaterals in ischemic heart disease. Br Heart J 38 (1976) 186-196
6. Thierfelder L., Holubarsch C.H., Hasefuss G., and Just H.J. Myocardial energetics in dilated cardiomyopathy. Clin Cardiol 13 (1990) 649-654
7. Parodi O., De Maria R., Oltrona L., et al. Myocardial blood flow distribution in patients ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 88 (1993) 509-522
8. Champagagne S., Hittinger L., Heloire F., et al. Reduced coronary vasodilator responses to amlodipine in pacing-induced heart failure in conscious dogs: role of nitric oxide. Br J Pharmacol 136 (2002) 264-270
9. Watzinger N., Lund G.K., Saeed M., et al. Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus. J Magn Reson Imaging 21 (2005) 347-353
10. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81 (1990) 772-779
11. Sudhir K., MacGregor J.S., Gupta M., et al. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo: intravascular two-dimensional and Doppler ultrasound studies. Circulation 87 (1993) 931-938
12. Neishi Y., Akasaka T., Tsukiji M., et al. Reduced coronary flow reserve in patients with congestive heart failure assessed by transthoracic Doppler echocardiography. J Am Soc Echocardiogr 18 (2005) 15-19
13. Nemes A., Forster T., and Csanady M. Simultaneous echocardiographic evaluation of coronary flow velocity reserve and aortic insufficiency. Heart Vessels 22 (2007) 73-78
14. Neglia D., Michelassi C., Giovanna Trvieri M., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002) 186
15. Xydas S., Rosen R.S., Pinney S., et al. Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. J Heart Lung Transplant 24 (2005) 1976-1979
16. Mundhenke M., Schwartzkopff B., Kosterling M., et al. Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy. Heart 81 (1999) 278-284
17. Nikolaidis L.A., Sturzu A., Stolarski C., et al. The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res 61 (2004) 297-306
18. Blain J.M., Schafer H., and Siegal A.L. Studies on myocardial metabolism. Am J Med 20 (1962) 820
19. Parrati J.R., Ledingham I M.C.A., and Macardale C.S. Effect of a coronary vasodilator drug (carbocromen) on blood flow and oxygen extraction in acute myocardial infarction. Cardiovasc Res 7 (1973) 401-407
20. Parodi O., De Maria R., Oitrona L., et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 88 (1993) 509-522
21. Neglia D., Parodi O., Gallopin M., et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. Circulation 92 (1995) 796-804
22. Taylor M., Williams T.R., Degrado T.R., et al. An evaluation of myocardial fatty acid and glucose uptake using PET with (18 F)fluro-6-rtia-hetadecanoic acid and glucose acid and (18 F) FDG in patients with congestive heart failure. J Nucl Med 42 (2001) 55-62
23. Davilia-Roman V.G., Vedala G., Herrero P., et al. Altered myocardial fatty acid glucose metabolism in dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 271-277
24. Wittles R.M., and Fowler M.B. Insulin-resistant cardiomyopathy. Clinical evidence, mechanisms, and treatment options. JACC 51 (2008) 93-102
25. Stolen K.Q., Kemppainen J., Kalliokoski K.K., et al. Myocardial perfusion reserve and peripheral endothelial function in patients with dilated cardiomyopathy. Am J Cardiol 93 (2004) 64-68
26. Coma-Canella I., Garcia-Velloso M.J., Macias A., et al. Impaired coronary flow reserve in patients with non-ischemic heart failure. Rev Esp Cardiol 56 (2003) 354-360
27. Canetti M., Akhter M.W., Lerman A., et al. Evaluation of myocardial blood flow reserve in patients with congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 92 (2003) 1246-1249
28. Mann D.L. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 91 (2002) 988-998
29. Pottluri S., Ventura H.O., Mullumudi M., and Mehra M.R. Cardiac troponin levels in heart failure. Cardiol Rev 12 (2004) 21-25
30. White M., Roleau J.L., Ruddy R.D., et al. Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. JACC 18 (1991) 1631-1637
31. Bersin R.M., Kwasman M Lau D., et al. Importance of oxygen-hemoglobin binding oxygen transport in congestive heart failure. Br Heart J 70 (1993) 443-447
32. Chatterjee K., De Marco T., and McGlothlin D. Remodeling in systolic heart failure-effects of neurohormonal modulators: basis for current pharmacotherapy. Cardiol Today 9 (2005) 270-277
33. Swedberg K., Viqerat C., Rouleau J.L., et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without heart failure. Am J Cardiol 54 (1984) 783-786
34. Eisenhofer G.W., Friberg P., Rundquest B., et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 (1996) 1667-1676
35. Leimbach J.R., Wallin B.G., Victor R.G., et al. Direct evidence from intraneural recordings for increased sympathetic outflow in patients with heart failure. Circulation 73 (1986) 913-919
36. Tamagawa K., Saito T., Oikawa Y., et al. Alteration of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure. J Cardiac Failure 11 (2005) 388-395
37. Sakanashi M., Tomomatssu E., Tako S., et al. Effect of dobutamine on coronary circulation and cardiac metabolism of the dog. Drug Res 28 (1978) 798-801
38. Chatterjee K. Effects of Dobutamine on coronary hemodynamics and myocardial energetics. In: Chatterjee K. (Ed). Dobutamine, a ten year review (1989), NCM Publishers Inc, New York 49-67
39. Foult J.M., Tavollaro O., Antony I., and Nitenberg A. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation 77 (1998) 337-344
40. Garnier A., Bendall J.K., Fuchs S., et al. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation 110 (2004) 1819-1825
41. Francis G.S., Benedict C., Jonston D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
42. Muller S., How O.J., Hermansen S.E., et al. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care 12 (2008) R20
43. Rodeheffer R.J., Lerman A., Heublein D.M., and Burnett J.C. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 67 (1992) 719
44. Cannan C.R., Burnett Jr. J.C., and Lerman A. Enhanced coronary vasoconstriction to Endothelin -B receptor activation in experimental congestive heart failure. Circulation 93 (1996) 645-651
45. Chen Y., Hou M., Li Y., et al. Increased superoxide production causes coronary endothelial dysfunction and depressed oxygen consumption in the failing heart. Am J Physiol Heart Circ Physiol 288 (2005) 133-141
46. De Marco T., Daly P.A., Liu M., et al. Enalaprilat: a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol 9 (1987) 1131-1138
47. Mohri M., Tagawa H., Egashira K., et al. Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 35 (2000) 249-255
48. Rouleau J.L., Chatterjee K., Benge W., et al. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure. Circulation 65 (1982) 671-678
49. Kiowski W., Zuber M., Elsasser S., et al. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure. Am Heart J 122 (1991) 1382-1388
50. Mattauer B., Rouleau J.L., and Daly P. The effect of captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease. Postgrad Med J 1 (1986) 54-58
51. Halperin J.L., Faxon D.P., Creager M.A., et al. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Am J Cardiol 50 (1982) 967-972
52. Van den Heuvel A.F., Blanksma P.K., Siebelink H.M., et al. Impairment of myocardial flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril. Int J Cardiovasc Imaging 17 (2001) 353-359
53. Erdogan D., Gullu H., Caliskan M., et al. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart 93 (2007) 319-324
54. Eichron E.J., Hesch C.M., Barnett J.H., et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 24 (1994) 1310-1320
55. Kono Y., Nakamura K., Kimura H., et al. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 70 (2006) 671-678
56. Magorien R.D., Brown G.P., Unverferth D.V., et al. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure. Circulation 65 (1982) 528-533
57. Gray R., Chatterjee K., Vyden J.K., et al. Hemodynamic and metabolic effects of isosorbide dinitrate in congestive heart failure. Am Heart J 90 (1975) 346-351
58. Michales A.D., Klein A., Madden J.A., et al. Effects of intravenous nesiritide on human coronary vasomotor tone and myocardial oxygen uptake. Circulation 107 (2003) 2697-2701
59. Wu G.F., Wykrzykowska J.J., Rana J.S., et al. Effects of B-type natriuretic peptide (nesiritide) on epicardial coronary arteries, systemic vasculature and microvessels. J Invasive Cardiol 20 (2008) 76-80
60. Forrester J., Bezdek W., Chatterjee K., et al. Hemodynamic effects of digitalis in acute myocardial infarction. Ann Intern Med 76 (1972) 863-864
61. Benderesky R., Chatterjee K., Parmley W.W., et al. Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics. Am J Cardiol 48 (1981) 76-80
62. Magorien R.D., Unverferth D.V., Brown G.P., and Leier C.V. Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and energetics in nonischemic congestive heart failure. J Am Coll Cardiol 1 (1983) 499-505
63. Takeuchi M., Sonoda S., Himeno E., et al. Comparative effects of dobutamine and amrinone on coronary blood flow in patients with idiopathic dilated cardiomyopathy. Cathet Cardiovasc Diagn 41 (1997) 157-163
64. Monrad E.S., Bain D.S., Smith H.S., et al. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 71 (1985) 972-979
65. Bennoti J.R., Grossman W., Braunwald E., and Carabello B.A. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62 (1980) 28-34
66. Knapen P., Linda M.C., van Campen C., et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 110 (2004) 646-651
67. Flevari P., Theodorakis G., Paraskeevalidis I., et al. Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement. Europace 8 (2006) 44-50
68. Yildrim A., Soyulu O., Dagdeviren B., et al. Cardiac resynchronization improves coronary blood flow. Tohoku J Exp Med 211 (2007) 43-47